Literature DB >> 10459988

ACE inhibitors and prevention of aspiration pneumonia in elderly hypertensives.

S Teramoto, Y Ouchi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10459988     DOI: 10.1016/S0140-6736(05)76506-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Evidence-based medicine (EBM) in the treatment of hypertension in older patients.

Authors:  S Teramoto; H Kume; T Matsuse
Journal:  J Gen Intern Med       Date:  2001-05       Impact factor: 5.128

Review 2.  Peripheral Organ Injury After Stroke.

Authors:  Jin Wang; Jiehua Zhang; Yingze Ye; Qingxue Xu; Yina Li; Shi Feng; Xiaoxing Xiong; Zhihong Jian; Lijuan Gu
Journal:  Front Immunol       Date:  2022-06-01       Impact factor: 8.786

Review 3.  Improving outcomes of elderly patients with community-acquired pneumonia.

Authors:  Félix Gutiérrez; Mar Masiá
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 4.  Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis.

Authors:  Daniel Caldeira; Joana Alarcão; António Vaz-Carneiro; João Costa
Journal:  BMJ       Date:  2012-07-11

Review 5.  [Gene polymorphism in intensive care patients. Is the course of disease predetermined?].

Authors:  S Ziegeler; S Kleinschmidt; C D Collard
Journal:  Anaesthesist       Date:  2004-03       Impact factor: 1.041

Review 6.  Use of ACE inhibitors and risk of community-acquired pneumonia: a review.

Authors:  Petros I Rafailidis; Dimitrios K Matthaiou; Ioannis Varbobitis; Matthew E Falagas
Journal:  Eur J Clin Pharmacol       Date:  2008-06       Impact factor: 3.064

Review 7.  Comparison of infection risks and clinical outcomes in patients with and without SARS-CoV-2 lung infection under renin-angiotensin-aldosterone system blockade: Systematic review and meta-analysis.

Authors:  Chang Chu; Shufei Zeng; Ahmed A Hasan; Carl-Friedrich Hocher; Bernhard K Krämer; Berthold Hocher
Journal:  Br J Clin Pharmacol       Date:  2020-12-18       Impact factor: 3.716

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.